Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895986 · ClinicalTrials.gov registry record · NA
Using Conversation Maps to Reinforce Self-Care
A NA study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT00895986 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 134 participants.
The verdict
NCT00895986, a NA study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
Many people with type 2 diabetes are not able to keep their blood glucose in good control. Improving blood glucose control and maintaining that improvement is important for diabetes patients because doing so delays the onset and progression of severe complications of diabetes. Although educational programs may be helpful, their effect is not always long-lasting. This project is studying whether the Conversation Maps program (an interactive diabetes education program) reinforces diabetes education and information and thus helps type 2 diabetes patients take better care of their diabetes and blood glucose levels. Half of the patients will attend the Conversation Maps program and half of the patients will attend an educational program about blood pressure and cholesterol. Also, all patients will come in for 4 or 5 appointments to complete surveys and other tests and have their blood drawn. The group of patients who attend the Conversation Maps program will be compared to the group of patients who attend the blood pressure and cholesterol program to see if the educational programs helped diabetes patients to improve their diabetes control and quality of life and to maintain that improvement over time.
Interventions
- BEHAVIORAL Conversation Maps Diabetes Education
- BEHAVIORAL Heart Healthy Living Diabetes Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00895986
The ClinicalTrials.gov registry entry for NCT00895986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conversation Maps Diabetes Education is the first listed.
NCT00895986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00895986 about?
NCT00895986 is a clinical study titled "Using Conversation Maps to Reinforce Self-Care". Many people with type 2 diabetes are not able to keep their blood glucose in good control. Improving blood glucose control and maintaining that improvement is important for diabetes patients because doing so delays the onset and progression of severe complications of diabetes. Although educational p...
What is the current status of trial NCT00895986?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2008-12. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00895986?
The interventions under investigation include: Conversation Maps Diabetes Education (BEHAVIORAL), Heart Healthy Living Diabetes Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00895986?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.